Key result
Patients with coronary heart disease and schizophrenia were 15% less likely to receive a recent statin prescription (95% CI 8% to 20% less likely) compared to those without these conditions.
Why the study?
Are patients with coronary heart disease and serious mental health problems less likely to receive guideline-directed primary care compared to those without these problems?
Population
127,932 UK patients with coronary heart disease, of whom 701 had a diagnosis of schizophrenia or bipolar…
Comparison
Diagnosis of schizophrenia or bipolar disorder vs Patients with CHD but without schizophrenia or…
Design
Cross-sectional
Authors
Loading...
Suggests care gaps for CHD patients with schizophrenia; leaves open causal pathways and equity interventions.
Cross-Sectional (n=127,932)
Yes
Are patients with coronary heart disease and serious mental health problems less likely to receive guideline-directed primary care compared to those without these problems?
Relative Risk: 0.85 (95% CI 0.8–0.92)
Patients with coronary heart disease and schizophrenia are less likely to receive statin prescriptions and cholesterol monitoring compared to those without serious mental illness, highlighting a gap in preventive care.
Hippisley‐Cox et al. (2007) conducted a cross-sectional in Coronary heart disease and serious mental health problems (n=127,932). Schizophrenia or bipolar disorder vs. Patients with neither condition was evaluated on Recent prescription for a statin (RR 0.85, 95% CI 0.80-0.92). Patients with coronary heart disease and schizophrenia were 15% less likely to receive a recent statin prescription (95% CI 8% to 20% less likely) compared to those without these conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: